No Data
H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $21
Wedbush Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $20
Analysts Are Bullish on Top Healthcare Stocks: Oric Pharmaceuticals (ORIC), Ufp Technologies (UFPT)
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Applied Therapeutics (APLT) and Oric Pharmaceuticals (ORIC)
ORIC Pharmaceuticals (ORIC) Up on Collaboration With Bayer & JNJ
Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
loading...